Equalis EQA s 2013 Preliminary Schedule For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group. Note: EQA programmes may appear in more than one group. This has been indicated by the following icons appearing next to the relevant programme names. Disease Group Key Disease Group Colour Icon Blood Borne Virus Central Nervous System Congenital Infection Drug Resistance Exotic Gastro Immunocompromised Respiratory Sexually Transmitted infection Transplant Typing QCMD EQA Pilot Studies 2013 A number of new EQA pilot studies may be introduced throughout 2013, and registration for these will be announced approximately 8 weeks prior to their EQA panel distribution. If you have requirements which are not supported by our current EQA offering, please contact the QCMD team (info@qcmd.org) for information about QCMD pilot studies. New EQA Pilot Studies are show as QCMD Regulatory EQAs in the groupings The regulatory EQA format will comprise of four challenges per year: Two full EQA panels (8-10 panel members) and two core EQA panels consisting of 4 panel members. The focus of these EQAs is on quantitative detection, and following each EQA challenge online reporting will enable participating labs to monitor their cumulative performance over time. NB: Registering for a Regulatory EQA will automatically subscribe you to the A & B EQAs for the selected pathogen. PreSh13-EQUALIS02 5 Technology Terrace, Todd Campus West of Scotland Science Park Glasgow, G20 0XA, Scotland Tel: +44 (0)141 945 6474, Fax: +44 (0)141 945 5795 E-mail: info@qcmd.org, Web: www.qcmd.org Page 1 of 8
Blood Borne Virus QAV034114 HIVDNA13A HIV-1 (DNA) Q1 Dry-ice QAV034116 B19DNA13 B19 Virus Q1 Dry-ice QAV034117 HCVGT13 HCV Genotyping Q1 Dry-ice QAV064118 HBVGT13 HBV Genotyping Q1 Dry-ice QAV024131 ENVA13 HIV-1 Drug Resistance Q3 Ambient QAV114146 ENVAINT13 HIV-1 Drug Resistance (Integrase) Q3 Ambient QAV034114 HIVDNA13B HIV-1 (DNA) Q3 Dry-ice QAV124156 HAVRNA13 Hepatitis A virus Q3 Dry-ice QAV124157 HEVRNA13 Hepatitis E virus Q3 Dry-ice QAV124160 HBVDR13 HBV Drug Resistance Q3 Dry-ice QAV134167 HCVDR13 HCV Drug Resistance Q3 Dry-ice HIV RNA EQA Range QAV994108 HIVRNA13A HIV-1 (RNA) Q1 Dry-ice QAV994108 HIVRNA13B HIV-1 (RNA) Q3 Dry-ice QAV124158 HIVRNAReg13 HIV-1 RNA regulatory programme (4 distributions per year) Q1-4 Dry-ice HBV RNA EQA Range QAV994110 HBVDNA13A Hepatitis B virus Q1 Dry-ice QAV994110 HBVDNA13B Hepatitis B virus Q3 Dry-ice QAV124159 HBVDNAReg13 HBV regulatory programme (4 distributions per year) Q1-4 Dry-ice HCV RNA EQA Range QAV994112 HCVRNA13A Hepatitis C virus Q1 Dry-ice QAV994112 HCVRNA13B Hepatitis C virus Q3 Dry-ice QAV124149 HCVRNAReg13 HCV regulatory programme (4 distributions per year) Q1-4 Dry-ice Page 2 of 8
Central Nervous System QAV034103 VZVDNA13 Varicella-Zoster virus Q1 Ambient QAV984104 EVRNA13 Enterovirus Q1 Ambient QAV114145 PeVRNA13 Parechovirus Q1 Ambient QAV994105 HSVDNA13 Herpes simplex virus 1& 2 Q1 Ambient QAV104141 WNVRNA13 West Nile Virus Q2 Ambient QAV114148 DENVRNA13 Dengue Virus Q2 Ambient QAV074106 JCBKDNA13 JC virus and BK virus Q2 Dry-ice QAP044123 TGDNA13 Toxoplasma gondii Q3 Ambient QAB114147 BbDNA13 Borrelia burgdorferi (Lyme's Disease) Q4 Dry-ice Congenital infection QAV064127 CMVDBS13 Cytomegalovirus Dried Blood Spots Q2 Ambient QAP044123 TGDNA13 Toxoplasma gondii Q3 Ambient Page 3 of 8
Drug Resistance QAB064124 MRSADNA13 Methicillin Resistant S. aureus Q2 Ambient QAV024131 ENVA13 HIV-1 Drug Resistance Q3 Ambient QAV114146 ENVAINT13 HIV-1 Drug Resistance (Integrase) Q3 Ambient QAB134162 ESBL13 Extended Spectrum ß-lactamase Q3 Dry-ice QAB134163 VRE13 Vancomycin Resistant Enterococci Q3 Dry-ice QAB134164 MRSASPA13 Methicillin Resistant S. aureus SPA Q3 Dry-ice QAV124160 HBVDR13 HBV Drug Resistance Q3 Dry-ice QAV134167 HCVDR13 HCV Drug Resistance Q3 Dry-ice Exotic QAV104141 WNVRNA13 West Nile Virus Q2 Ambient QAV114148 DENVRNA13 Dengue Virus Q2 Ambient Page 4 of 8
Gastro QAB084125 CDDNA13 Clostridium difficile Q2 Ambient QAV054133 ADVDNA13 Adenovirus Q4 Dry-ice QAV084139 NVRNA13 Norovirus Q4 Dry-ice QAV124152 GastroV13 Viral Gastroenteritis Q4 Dry-ice QAB124153 GastroB13 Bacterial Gastroenteritis Q4 Dry-ice QAP124154 GastroP13 Parasitic Gastroenteritis Q4 Dry-ice Immunocompromised QAV074106 JCBKDNA13 JC virus and BK virus Q2 Dry-ice QAV084119 HHV6DNA13 Human Herpes Virus 6 Q2 Dry-ice QAV014120 CMVDNA13 Human Cytomegalovirus Q2 Dry-ice QAV124150 CMVWB13 Human Cytomegalovirus Whole Blood Q2 Dry-ice QAV024121 EBVDNA13 Epstein-Barr virus Q2 Dry-ice QAV134161 EBVWB13 Epstein-Barr virus whole blood Q2 Dry-ice QAP044123 TGDNA13 Toxoplasma gondii Q3 Ambient QAF104140 ASPDNA13 Aspergillus Q4 Dry-ice QAF124151 C.ALBDNA13 Candida albicans Q4 Dry-ice QAF114144 PCPDNA13 Pneumocystis jirovecii pneumonia (PCP) Q4 Dry-ice Page 5 of 8
Respiratory QAB084107 CP.MP13 Chlamydophila pneumoniae and Mycoplasma pneumoniae Q2 Ambient QAB044122 LPDNA13 Legionella pneumophila Q2 Ambient QAB014129 MTBDNA13 M. tuberculosis Complex Q3 Ambient QAB094132 BPDNA13 Bordetella pertussis Q4 Dry-ice QAV054133 ADVDNA13 Adenovirus Q4 Dry-ice QAV054134 INFRNA13 Influenza A & B virus Q4 Dry-ice QAV054135 MPV13 Human Metapneumovirus Q4 Dry-ice QAV054142 RSV13 Respiratory Syncytial Virus Q4 Dry-ice QAV064136 PINFRNA13 Parainfluenza virus Q4 Dry-ice QAV064137 CVRNA13 Coronavirus Q4 Dry-ice QAV064143 RVRNA13 Rhinovirus Q4 Dry-ice QAV064138 INFHT13 Influenza Haemagglutinin Typing Q4 Dry-ice QAB134165 CPS13 Chlamydia psittaci Q4 Dry-ice QAF114144 PCPDNA13 Pneumocystis jirovecii pneumonia (PCP) Q4 Dry-ice Page 6 of 8
Sexually Transmitted infections QAB004101 CTDNA13A Chlamydia trachomatis A Q1 Ambient QAV994105 HSVDNA13 Herpes simplex virus 1& 2 Q1 Ambient QAB004101 CTDNA13B Chlamydia trachomatis B Q2 Ambient QAB034126 NgDNA13 Neisseria gonorrhoeae Q2 Ambient QAV094130 HPVDNA13 Human Papillomavirus Q3 Ambient / Specialist* Transplant QAV074106 JCBKDNA13 JC virus and BK virus Q2 Dry-ice QAV084119 HHV6DNA13 Human Herpes Virus 6 Q2 Dry-ice QAV014120 CMVDNA13 Human Cytomegalovirus Q2 Dry-ice QAV124150 CMVWB13 Human Cytomegalovirus Whole Blood Q2 Dry-ice QAV024121 EBVDNA13 Epstein-Barr virus Q2 Dry-ice QAV134161 EBVWB13 Epstein-Barr virus whole blood Q2 Dry-ice QAP044123 TGDNA13 Toxoplasma gondii Q3 Ambient QAV054133 ADVDNA13 Adenovirus Q4 Dry-ice Page 7 of 8
Typing QAV034117 HCVGT13 HCV Genotyping Q1 Dry-ice QAV064118 HBVGT13 HBV Genotyping Q1 Dry-ice QAB074128 MRSATP13 Methicillin Resistant S. aureus Typing Q2 Ambient QAV024131 ENVA13 HIV-1 Drug Resistance Q3 Ambient QAV114146 ENVAINT13 HIV-1 Drug Resistance (Integrase) Q3 Ambient QAB134164 MRSASPA13 Methicillin Resistant S. aureus SPA Q3 Dry-ice QAV124160 HBVDR13 HBV Drug Resistance Q3 Dry-ice QAV134167 HCVDR13 HCV Drug Resistance Q3 Dry-ice QAV064138 INFHT13 Influenza Haemagglutinin Typing Q4 Dry-ice QAB124155 MALDIBAC13 MALDI-TOF Bacterial Q4 Dry-ice New EQA Pilot Studies for 2013 QAV134161 EBVWB13 Epstein-Barr virus whole blood Q2 Dry-ice QAB134162 ESBL13 Extended Spectrum ß-lactamase Q3 Dry-ice QAB134163 VRE13 Vancomycin Resistant Enterococci Q3 Dry-ice QAB134164 MRSASPA13 Methicillin Resistant S. aureus SPA Q3 Dry-ice QAV134167 HCVDR13 HCV Drug Resistance Q3 Dry-ice QAB134165 CPS13 Chlamydia psittaci Q4 Dry-ice Page 8 of 8